These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24037493)

  • 1. Effects of the fatty acid amide hydrolase inhibitor URB597 on coping behavior under challenging conditions in mice.
    Haller J; Aliczki M; Pelczer KG; Spitzer K; Balogh Z; Kantor S
    Psychopharmacology (Berl); 2014 Feb; 231(3):593-601. PubMed ID: 24037493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of anandamide signaling enhanced by the FAAH inhibitor URB597 on coping styles in rats.
    Haller J; Goldberg SR; Pelczer KG; Aliczki M; Panlilio LV
    Psychopharmacology (Berl); 2013 Dec; 230(3):353-62. PubMed ID: 23743650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition.
    Scherma M; Medalie J; Fratta W; Vadivel SK; Makriyannis A; Piomelli D; Mikics E; Haller J; Yasar S; Tanda G; Goldberg SR
    Neuropharmacology; 2008 Jan; 54(1):129-40. PubMed ID: 17904589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Fatty Acid Amide Hydrolase Improves Depressive-Like Behaviors Independent of Its Peripheral Antinociceptive Effects in a Rat Model of Neuropathic Pain.
    Jiang HX; Ke BW; Liu J; Ma G; Hai KR; Gong DY; Yang Z; Zhou C
    Anesth Analg; 2019 Aug; 129(2):587-597. PubMed ID: 29863609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat.
    Cippitelli A; Cannella N; Braconi S; Duranti A; Tontini A; Bilbao A; Defonseca FR; Piomelli D; Ciccocioppo R
    Psychopharmacology (Berl); 2008 Jul; 198(4):449-60. PubMed ID: 18446329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
    Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
    Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of endocannabinoid-degrading enzyme fatty acid amide hydrolase increases atherosclerotic plaque vulnerability in mice.
    Hoyer FF; Khoury M; Slomka H; Kebschull M; Lerner R; Lutz B; Schott H; Lütjohann D; Wojtalla A; Becker A; Zimmer A; Nickenig G
    J Mol Cell Cardiol; 2014 Jan; 66():126-32. PubMed ID: 24286707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects anandamide signaling in the prelimbic cortex and basolateral amygdala on coping with environmental stimuli in rats.
    Aliczki M; Barna I; Till I; Baranyi M; Sperlagh B; Goldberg SR; Haller J
    Psychopharmacology (Berl); 2016 May; 233(10):1889-99. PubMed ID: 26809457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of endocannabinoid and endovanilloid systems on aversive memory extinction.
    Laricchiuta D; Centonze D; Petrosini L
    Behav Brain Res; 2013 Nov; 256():101-7. PubMed ID: 23948212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats.
    Scherma M; Panlilio LV; Fadda P; Fattore L; Gamaleddin I; Le Foll B; Justinová Z; Mikics E; Haller J; Medalie J; Stroik J; Barnes C; Yasar S; Tanda G; Piomelli D; Fratta W; Goldberg SR
    J Pharmacol Exp Ther; 2008 Nov; 327(2):482-90. PubMed ID: 18725543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of fatty acid amide hydrolase and monoacylglycerol lipase inhibitor treatments on lipopolysaccharide-induced airway inflammation in mice.
    Abohalaka R; Bozkurt TE; Nemutlu E; Onder SC; Sahin-Erdemli I
    Pulm Pharmacol Ther; 2020 Jun; 62():101920. PubMed ID: 32416152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased Contextual Fear Conditioning in iNOS Knockout Mice: Additional Evidence for the Involvement of Nitric Oxide in Stress-Related Disorders and Contribution of the Endocannabinoid System.
    Lisboa SF; Gomes FV; Silva AL; Uliana DL; Camargo LH; Guimarães FS; Cunha FQ; Joca SR; Resstel LB
    Int J Neuropsychopharmacol; 2015 Jan; 18(8):. PubMed ID: 25618404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the fatty acid amide hydrolase inhibitor URB597 on pain-stimulated and pain-depressed behavior in rats.
    Kwilasz AJ; Abdullah RA; Poklis JL; Lichtman AH; Negus SS
    Behav Pharmacol; 2014 Apr; 25(2):119-29. PubMed ID: 24583930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.
    Fegley D; Gaetani S; Duranti A; Tontini A; Mor M; Tarzia G; Piomelli D
    J Pharmacol Exp Ther; 2005 Apr; 313(1):352-8. PubMed ID: 15579492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty acid amide hydrolase inhibition for the symptomatic relief of Parkinson's disease.
    Celorrio M; Fernández-Suárez D; Rojo-Bustamante E; Echeverry-Alzate V; Ramírez MJ; Hillard CJ; López-Moreno JA; Maldonado R; Oyarzábal J; Franco R; Aymerich MS
    Brain Behav Immun; 2016 Oct; 57():94-105. PubMed ID: 27318096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality.
    Naidu PS; Varvel SA; Ahn K; Cravatt BF; Martin BR; Lichtman AH
    Psychopharmacology (Berl); 2007 May; 192(1):61-70. PubMed ID: 17279376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of fatty acid amide hydrolase activates Nrf2 signalling and induces heme oxygenase 1 transcription in breast cancer cells.
    Li H; Wood JT; Whitten KM; Vadivel SK; Seng S; Makriyannis A; Avraham HK
    Br J Pharmacol; 2013 Oct; 170(3):489-505. PubMed ID: 23347118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of effect of chronic pre-treatment with the FAAH inhibitor URB597 on inflammatory pain behaviour: evidence for plastic changes in the endocannabinoid system.
    Okine BN; Norris LM; Woodhams S; Burston J; Patel A; Alexander SP; Barrett DA; Kendall DA; Bennett AJ; Chapman V
    Br J Pharmacol; 2012 Oct; 167(3):627-40. PubMed ID: 22595021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty Acid Amide Hydrolase (FAAH) Inhibition Modulates Amyloid-Beta-Induced Microglia Polarization.
    Grieco M; De Caris MG; Maggi E; Armeli F; Coccurello R; Bisogno T; D'Erme M; Maccarrone M; Mancini P; Businaro R
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of fatty-acid amide hydrolyse (FAAH) exerts cognitive improvements in male but not female rats.
    Hlavacova N; Chmelova M; Danevova V; Csanova A; Jezova D
    Endocr Regul; 2015 Jul; 49(3):131-6. PubMed ID: 26238495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.